Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors

摘要

#$%^&*AU2017228472B220190711.pdf#####ABSTRACT This invention relates to improvements in therapeutic neurological and neuropsychic treatments using acetylcholinesterase inhibitors. More specifically, the invention enables the effects of a reversible acetylcholinesterase inhibitor to be potentiated by certain molecules, referred to here as 5 connexin-blocking agents. Said connexin-blocking agent ispreferably meclofenamic acid.